Earnings History Data for Regulus Therapeutics (RGLS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Regulus Therapeutics
Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulus Therapeutics Inc. is based in La Jolla, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | AH | RGLS | Regulus Therapeutics | 98.00 | -0.21 | -0.18 | 0.00 | Regulus Therapeutics GAAP EPS of -$0.21 misses by $0.04 [11/7/2024 6:11 PM] |
1.46 | -0.02 (-1.36%) |
1.52 | 0.04 (2.71%) |
1.08 - 3.79 | 241,838 | 660,000 | 1,949 | ||
| 08-08-2024 | AH | RGLS | Regulus Therapeutics | 100.00 | -0.17 | -0.17 | 0.00 | Regulus Therapeutics GAAP EPS of -$0.17 misses by $0.02 [8/8/2024 6:54 PM] |
1.48 | 0.0 (0.00%) |
1.53 | 0.05 (3.38%) |
1.08 - 3.79 | 171,378 | 490,000 | 6,372 | ||
| 21-03-2024 | AH | RGLS | Regulus Therapeutics | 48.00 | -0.40 | -0.40 | 0.00 | Regulus Therapeutics GAAP EPS of -$0.40 in-line [3/21/2024 4:46 PM] |
2.66 | -0.12 (-4.32%) |
2.84 | 0.06 (2.16%) |
0.77 - 3.79 | 628,009 | 18,160,000 | 14,527 | ||
| 08-08-2023 | AH | RGLS | Regulus Therapeutics | 27.00 | -0.37 | -0.39 | 0.00 | Regulus Therapeutics GAAP EPS of -$0.37 beats by $0.04 [8/8/2023 5:29 PM] |
1.35 | 0.02 (1.50%) |
0.0 | 0.0 (0.00%) |
0.76 - 2.40 | 3,542 | 10,000 | 0 | ||
| 10-11-2022 | AH | 4:10 PM ET (Nov 10) |
RGLS | Regulus Therapeutics Inc. | 26.20 | -0.50 | -0.50 | 1.00 | Regulus Therapeutics GAAP EPS of -$0.50 [11/10/2022 4:20 PM] |
1.64 | 0.01 (0.92%) |
1.83 | 0.21 (12.62%) |
1.33 - 4.37 | 23,744 | 50,000 | 101 | |
| 11-08-2022 | AH | 4:05 PM ET (Aug 11) |
RGLS | Regulus Therapeutics Inc. | 25.40 | -0.50 | -0.46 | -0.80 | 1.74 | 0.09 (5.51%) |
1.60 | -0.05 (-3.03%) |
1.42 - 8.72 | 72,855 | 200,000 | 1,329 | ||
| 12-05-2022 | AH | 4:05 PM ET (May 12) |
RGLS | Regulus Therapeutics Inc. | 25.08 | -0.05 | -0.05 | -0.08 | Regulus Therapeutics GAAP EPS of -$0.05 [5/12/2022 4:09 PM] |
0.22 | -0.03 (-10.42%) |
0.20 | -0.04 (-17.30%) |
0.16 - 1.48 | 3,049,842 | 7,250,000 | 89,227 | |
|
||||||||||||||||||
| 10-03-2022 | AH | 4:05 PM ET (Mar 10) |
RGLS | Regulus Therapeutics Inc. | 42.14 | -0.07 | -0.05 | -0.03 | Regulus Therapeutics GAAP EPS of -$0.07 [3/10/2022 4:10 PM] |
0.2861 | -0.02 (-5.26%) |
0.30 | -0.01 (-1.66%) |
0.19 - 2.32 | 848,439 | 2,480,000 | 20,357 | |
| 10-11-2021 | AH | 4:05 PM ET (Nov 10) |
RGLS | Regulus Therapeutics Inc. | 41.61 | -0.10 | -0.07 | -0.04 | Regulus Therapeutics EPS misses by $0.02, revenue in-line [11/10/2021 4:20 PM] |
0.4179 | -0.02 (-4.30%) |
0.43 | -0.01 (-1.53%) |
0.42 - 2.32 | 1,212,497 | 2,060,000 | 44,188 | |
| 10-08-2021 | AH | 4:05 PM ET (Aug 10) |
RGLS | Regulus Therapeutics Inc. | 54.21 | -0.08 | -0.08 | -0.23 | Regulus Therapeutics EPS in-line [8/10/2021 4:28 PM] |
0.72 | -0.01 (-1.95%) |
0.77 | 0.04 (4.86%) |
0.42 - 2.32 | 1,018,252 | 890,000 | 128,663 | |
| 13-05-2021 | AH | 4:05 PM ET (May 13) |
RGLS | Regulus Therapeutics Inc. | 64.18 | -0.08 | -0.09 | -0.25 | Regulus Therapeutics EPS beats by $0.01 [5/13/2021 4:35 PM] |
0.8899 | 0.07 (8.52%) |
0.88 | 0.06 (7.68%) |
0.42 - 2.32 | 1,319,994 | 1,840,000 | 33,636 | |
|
||||||||||||||||||
| 09-03-2021 | AH | 4:05 PM ET (Mar 9) |
RGLS | Regulus Therapeutics Inc. | 51.00 | -0.03 | -0.10 | 0.00 | Regulus Therapeutics EPS of -$0.03 [3/9/2021 4:29 PM] |
1.35 | -0.02 (-1.46%) |
1.38 | 0.01 (0.73%) |
0.42 - 1.97 | 1,650,149 | 2,286,586 | 128,157 | |
| 13-08-2020 | AH | RGLS | Regulus Therapeutics Inc. | 19.54 | -0.23 | -0.20 | -0.30 | Regulus Therapeutics EPS misses by $0.12 [8/13/2020 4:39 PM] |
0.6250 | -0.01 (-2.11%) |
0.64 | 0.0 (0.23%) |
0.43 - 1.74 | 496,557 | 1,499,364 | 43,237 | ||
|
|
||||||||||||||||||
| 14-05-2020 | AH | RGLS | Regulus Therapeutics Inc. | 20.99 | -0.25 | -0.01 | -0.31 | Regulus Therapeutics EPS misses by $0.13 [5/14/2020 4:24 PM] |
0.5990 | -0.06 (-9.24%) |
0.60 | 0.0 (0.17%) |
0.43 - 1.74 | 491,610 | 606,682 | 4,801 | ||
|
|
||||||||||||||||||